160 related articles for article (PubMed ID: 27117753)
1. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial.
Bignami E; Cattaneo M; Crescenzi G; Ranucci M; Guarracino F; Cariello C; Baldassarri R; Isgrò G; Baryshnikova E; Fano G; Franco A; Gerli C; Crivellari M; Zangrillo A; Landoni G
Acta Anaesthesiol Scand; 2016 Aug; 60(7):892-900. PubMed ID: 27117753
[TBL] [Abstract][Full Text] [Related]
2. Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial.
Despotis GJ; Levine V; Saleem R; Spitznagel E; Joist JH
Lancet; 1999 Jul; 354(9173):106-10. PubMed ID: 10408485
[TBL] [Abstract][Full Text] [Related]
3. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery.
Hackmann T; Gascoyne RD; Naiman SC; Growe GH; Burchill LD; Jamieson WR; Sheps SB; Schechter MT; Townsend GE
N Engl J Med; 1989 Nov; 321(21):1437-43. PubMed ID: 2682243
[TBL] [Abstract][Full Text] [Related]
4. The effect of desmopressin on reducing blood loss in cardiac surgery--a meta-analysis of double-blind, placebo-controlled trials.
Cattaneo M; Harris AS; Strömberg U; Mannucci PM
Thromb Haemost; 1995 Oct; 74(4):1064-70. PubMed ID: 8560415
[TBL] [Abstract][Full Text] [Related]
5. Effect of Desmopressin on the Amount of Bleeding and Transfusion Requirements in Patients Undergoing Heart Transplant Surgery.
Jahangirifard A; Razavi MR; Ahmadi ZH; Forozeshfard M
Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):175-180. PubMed ID: 28326680
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery.
Pleym H; Stenseth R; Wahba A; Bjella L; Tromsdal A; Karevold A; Dale O
Anesth Analg; 2004 Mar; 98(3):578-84, table of contents. PubMed ID: 14980901
[TBL] [Abstract][Full Text] [Related]
7. Desmopressin treatment improves platelet function under flow in patients with postoperative bleeding.
Swieringa F; Lancé MD; Fuchs B; Feijge MA; Solecka BA; Verheijen LP; Hughes KR; van Oerle R; Deckmyn H; Kannicht C; Heemskerk JW; van der Meijden PE
J Thromb Haemost; 2015 Aug; 13(8):1503-13. PubMed ID: 25988848
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
[TBL] [Abstract][Full Text] [Related]
9. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial.
Salzman EW; Weinstein MJ; Weintraub RM; Ware JA; Thurer RL; Robertson L; Donovan A; Gaffney T; Bertele V; Troll J
N Engl J Med; 1986 May; 314(22):1402-6. PubMed ID: 3517650
[TBL] [Abstract][Full Text] [Related]
10. Desmopressin acetate in cardiac surgery: a double-blind, randomized study.
Temeck BK; Bachenheimer LC; Katz NM; Coughlin SS; Wallace RB
South Med J; 1994 Jun; 87(6):611-5. PubMed ID: 8202769
[TBL] [Abstract][Full Text] [Related]
11. Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults.
Wademan BH; Galvin SD
Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):360-70. PubMed ID: 24263581
[TBL] [Abstract][Full Text] [Related]
12. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study.
Casas JI; Zuazu-Jausoro I; Mateo J; Oliver A; Litvan H; Muñiz-Díaz E; Arís A; Caralps JM; Fontcuberta J
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):1107-17. PubMed ID: 7475139
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
14. Desmopressin usage in elective cardiac surgery.
Ozkisacik E; Islamoğlu F; Posacioğlu H; Yağdi T; Başarir S; Omay SB; Ozbaran M; Büket S
J Cardiovasc Surg (Torino); 2001 Dec; 42(6):741-7. PubMed ID: 11698939
[TBL] [Abstract][Full Text] [Related]
15. Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials.
Desborough MJ; Oakland KA; Landoni G; Crivellari M; Doree C; Estcourt LJ; Stanworth SJ
J Thromb Haemost; 2017 Feb; 15(2):263-272. PubMed ID: 27893176
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
17. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass.
de Prost D; Barbier-Boehm G; Hazebroucq J; Ibrahim H; Bielsky MC; Hvass U; Lacombe C; Français JL; Desmonts JM
Thromb Haemost; 1992 Aug; 68(2):106-10. PubMed ID: 1412152
[TBL] [Abstract][Full Text] [Related]
18. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery.
Horrow JC; Van Riper DF; Strong MD; Brodsky I; Parmet JL
Circulation; 1991 Nov; 84(5):2063-70. PubMed ID: 1934382
[TBL] [Abstract][Full Text] [Related]
19. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery.
Weber CF; Dietrich W; Spannagl M; Hofstetter C; Jámbor C
Anesth Analg; 2010 Mar; 110(3):702-7. PubMed ID: 20042444
[TBL] [Abstract][Full Text] [Related]
20. A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).
Bokesch PM; Szabo G; Wojdyga R; Grocott HP; Smith PK; Mazer CD; Vetticaden S; Wheeler A; Levy JH
J Thorac Cardiovasc Surg; 2012 May; 143(5):1022-9. PubMed ID: 21724197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
